Literature DB >> 3190693

Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides.

S Suzuki1, B Lee, W Luo, D Tovell, M J Robins, D L Tyrrell.   

Abstract

Primary hepatocyte cultures from duck hepatitis B virus (DHBV) infected ducklings were used to evaluate the antiviral activity of purine and pyrimidine 2',3'-dideoxynucleosides. The purine 2',3'-dideoxynucleosides were very effective inhibitors of hepadnavirus replication, whereas the pyrimidine dideoxynucleosides were not. 2',3'-Dideoxyguanosine and 2,6-diaminopurine 2',3'-dideoxyriboside (ddDAPR) were the most effective antiviral agents studied. ddDAPR given intramuscularly twice daily at 10 mg/kg rapidly cleared DHBV-DNA from the sera of persistently infected ducklings but this effect was not permanent.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190693     DOI: 10.1016/s0006-291x(88)80752-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  The intracellular activation of lamivudine (3TC) and determination of 2'-deoxycytidine-5'-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells.

Authors:  S Kewn; P G Hoggard; S D Sales; M A Johnson; D J Back
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

2.  Sulfated polyanions do not inhibit duck hepatitis B virus infection.

Authors:  W B Offensperger; S Offensperger; E Walter; H E Blum; W Gerok
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.

Authors:  T Yokota; K Konno; E Chonan; S Mochizuki; K Kojima; S Shigeta; E de Clercq
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

4.  In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus.

Authors:  T Shaw; P Amor; G Civitico; M Boyd; S Locarnini
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

5.  Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen.

Authors:  Kathie-Anne Walters; Michael A Joyce; William R Addison; Karl P Fischer; D Lorne J Tyrrell
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Pharmacodynamics of (-)-beta-2',3'-dideoxy-3'-thiacytidine in chronically virus-infected woodchucks compared to its pharmacodynamics in humans.

Authors:  S J Hurwitz; B C Tennant; B E Korba; J L Gerin; R F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosides.

Authors:  E Matthes; P Langen; M von Janta-Lipinski; H Will; H C Schröder; H Merz; B E Weiler; W E Müller
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

8.  Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.

Authors:  P Hafkemeyer; A Keppler-Hafkemeyer; M A al Haya; M von Janta-Lipinski; E Matthes; C Lehmann; W B Offensperger; S Offensperger; W Gerok; H E Blum
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.

Authors:  S L Doong; C H Tsai; R F Schinazi; D C Liotta; Y C Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Inhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidine.

Authors:  J O Ojwang; B K Bhattacharya; H B Marshall; B E Korba; G R Revankar; R F Rando
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.